Sodium Bicarbonate for the Treatment of Severe Metabolic Acidosis With Moderate or Severe Acute Kidney Injury in ICU

NACompletedINTERVENTIONAL
Enrollment

640

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

December 19, 2023

Study Completion Date

June 17, 2024

Conditions
Metabolic AcidosisAcute Kidney Injury
Interventions
DRUG

Sodium bicarbonate infusion

"Patients randomly assigned to bicarbonate group will receive intravenous 4.2% sodium bicarbonate titrated from 125ml to 250ml in 30min at physician's discretion to target a pH equal or above 7.30. Bicarbonate infusion will be repeated up to 1000ml per 24h. Arterial blood gases will be repeated from 3 to 6 times during the first 24h at physician's discretion.~Bicarbonate infusion recommendations will be as follow: a central line is recommended, infusion will be slow (125-250ml in 30 min, no intravenous push), careful surveillance of metabolic alkalosis, cardiogenic pulmonary edema, kalemia, natremia and calcemia. Repeated arterial blood gases will be suggested to monitor these critically ill patients and physicians will be reinformed of the potential side effects of sodium bicarbonate infusion."

Trial Locations (1)

34000

Service de médecine intensive et réanimation, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04010630 - Sodium Bicarbonate for the Treatment of Severe Metabolic Acidosis With Moderate or Severe Acute Kidney Injury in ICU | Biotech Hunter | Biotech Hunter